Related Experiment Video
Updated: Jun 14, 2026
Mouse Model of Surgically-induced Endometriosis by Auto-transplantation of Uterine Tissue
Published on: January 6, 2012
Efficacy of anti-tumor necrosis factor therapy on endometriosis in an experimental rat model
Ebru Zulfikaroglu1, Sevtap Kılıc, Mine Islimye
1Department of Obstetrics and Gynecology, Ankara Dr Zekai Tahir Burak Women Health Teaching and Research Hospital, 7.Cadde 70 A/14, Bahcelievler, 06490 Ankara, Turkey. zebru33@hotmail.com
Objective:
To show the efficacy of anti-tumor necrosis factor therapy (etanercept) for treating endometriosis in an experimental model.
Design:
A randomized, placebo-controlled, blinded study using rat endometriosis model.
Setting:
Experimental research center of Ankara Education and Research Hospital.
Animal(S):
Twenty-two Wistar female rats.
Intervention(S):
After peritoneal implantation of endometrial tissue, rats were randomized to two equal intervention groups: control and etanercept-treated groups. After measuring implant volume, blood and peritoneal fluid samples were obtained. Vehicle treatments of 2 mL saline to rats in control and 0.4 mg/kg etanercept SC once weekly were administered in treatment group. Four weeks later, a third laparotomy was performed to remeasure implant volumes, blood, and peritoneal fluid samples.
Main Outcome Measure(S):
To compare spherical volume, peritoneal fluid and serum levels of VEGF, IL-6, and TNF-α between groups.
Result(S):
There was a significant difference in spherical volume between control [131.0 (60.3-501.2)] and treatment groups [72.8 (31.2-149.6)] (p < 0.025). In etanercept-treated group, a significant difference was found between peritoneal fluid and serum levels of VEGF, IL-6, and TNF-α (p < 0.01).
Conclusion(S):
These results indicate that etanercept was found to effectively reduce the development of endometriosis.
